DRI drew the most analyst attention this session. Three brokers moved their targets after the restaurant group's latest results.
Mizuho and Freedom Capital Markets both raised targets. Mizuho went to $245 from $235. Freedom Capital went to $260 from $255. Both kept Buy ratings.
BMO Capital went the other way. It cut its target to $220 from $225 and held at Hold. The split signals uncertainty about near-term traffic trends even as headline numbers impressed.
CRL also drew multiple upgrades. Barclays raised its target to $330 from $300 and kept Buy. Mizuho lifted to $295 from $264. Charles River provides contract research services to biopharma. The moves suggest analysts see biotech spending recovering.
Bernstein started CF at Buy with a $162 target. CF Industries makes nitrogen fertilisers. Bernstein cited strong pricing dynamics and tight global supply.
StoneX initiated TSLA at Buy with a $475 price target. That sits near the upper end of the Wall Street range. Consensus on Tesla is divided, with 19 Sell ratings against 4 Buys.
saw two brokers trim targets. Mizuho cut to $1,065 from $1,100. Bernstein nudged down to $1,143 from $1,144. Both kept Buy ratings. Analysts remain broadly positive but see limited near-term upside after a strong run.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
